Akari Therapeutics, Plc (AKTX)

Akari Therapeutics, Statistics

Total Valuation

AKTX has a market cap or net worth of $6.34 million. The enterprise value is $2.11 million.

Market Cap	6.34M
Enterprise Value	2.11M

Important Dates

The next estimated earnings date is Thursday, May 14, 2026, before market open.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

AKTX has 1.13 million shares outstanding. The number of shares has increased by 181.85% in one year.

Current Share Class	n/a
Shares Outstanding	1.13M
Shares Change (YoY)	+181.85%
Shares Change (QoQ)	+32.27%
Owned by Insiders (%)	54.61%
Owned by Institutions (%)	4.23%
Float	435,628

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.23
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.44, with a Debt / Equity ratio of 0.03.

Current Ratio	0.44
Quick Ratio	0.42
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-12.74

Financial Efficiency

Return on equity (ROE) is -68.43% and return on invested capital (ROIC) is -27.70%.

Return on Equity (ROE)	-68.43%
Return on Assets (ROA)	-15.36%
Return on Invested Capital (ROIC)	-27.70%
Return on Capital Employed (ROCE)	-34.03%
Weighted Average Cost of Capital (WACC)	16.70%
Revenue Per Employee	n/a
Profits Per Employee	-$2.88M
Employee Count	6
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-1.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -89.79% in the last 52 weeks. The beta is 0.54, so AKTX's price volatility has been lower than the market average.

Beta (5Y)	0.54
52-Week Price Change	-89.79%
50-Day Moving Average	7.12
200-Day Moving Average	21.57
Relative Strength Index (RSI)	50.87
Average Volume (20 Days)	67,725

Short Selling Information

The latest short interest is 14,622, so 4.66% of the outstanding shares have been sold short.

Short Interest	14,622
Short Previous Month	5,810
Short % of Shares Out	4.66%
Short % of Float	n/a
Short Ratio (days to cover)	0.48

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-12.10M
Pretax Income	-18.30M
Net Income	-17.30M
EBITDA	-12.08M
EBIT	-12.10M
Earnings Per Share (EPS)	-$20.55

Balance Sheet

The company has $5.20 million in cash and $754,000 in debt, with a net cash position of $4.45 million or $3.93 per share.

Cash & Cash Equivalents	5.20M
Total Debt	754,000
Net Cash	4.45M
Net Cash Per Share	$3.93
Equity (Book Value)	28.33M
Book Value Per Share	25.03
Working Capital	-6.89M

Cash Flow

Operating Cash Flow	-10.57M
Capital Expenditures	n/a
Depreciation & Amortization	14,000
Net Borrowing	1.05M
Free Cash Flow	-10.57M
FCF Per Share	-$9.34

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AKTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-181.85%
Shareholder Yield	-181.85%
Earnings Yield	-263.53%
FCF Yield	-161.00%

Analyst Forecast

The average price target for AKTX is $33.50, which is 498.21% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$33.50
Price Target Difference	498.21%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 31, 2026. It was a reverse split with a ratio of 1:40.

Last Split Date	Mar 31, 2026
Split Type	Reverse
Split Ratio	1:40

Scores

Altman Z-Score	n/a
Piotroski F-Score	2